Lysine is not an established treatment for canker sores. The strongest rationale comes from laboratory work on herpes simplex virus, not from aphthous ulcers, so any benefit for canker sores is extrapolated rather than proven. The few small trials that tested lysine in people with recurrent canker sores produced mixed results, and no major clinical guideline recommends it as primary therapy. A reasonable reading of the evidence: lysine is low-risk and inexpensive, but it is not a reliable fix.
Canker sores, clinically called recurrent aphthous stomatitis or RAS, are painful ulcers inside the mouth that are not caused by the herpes virus. That distinction matters because lysine's best-known use is in herpes labialis, the cold sore caused by HSV-1. Many people, and many thin web articles, collapse the two conditions into one. They are different diseases with different biology, and evidence from one does not transfer cleanly to the other. This explainer separates what is mechanistically plausible from what has actually been measured in people with canker sores.
The lysine mechanism and why it may not apply
Lysine is an essential amino acid, meaning the body cannot make it and must obtain it from food or supplements. Its proposed antiviral action rests on a specific biochemical relationship: HSV-1 replication depends on arginine, another amino acid, and lysine competes with arginine for transport into cells and for incorporation into viral proteins. Raising lysine relative to arginine is thought to starve the virus of the arginine it needs. That is a coherent model for herpes, and it is why lysine supplements became popular for cold sores.
Canker sores have a different origin. They are not viral. Current understanding points to a localized immune response in the mouth lining, triggered by minor trauma, stress, certain foods, hormonal shifts, or genetic susceptibility. Some people with RAS show low levels of certain nutrients, but lysine deficiency is not a recognized cause. Because there is no arginine-dependent virus to starve, the central rationale for lysine in herpes does not have an obvious target in canker sores. Any effect would have to come through a different, less understood route, such as effects on mucosal repair or immune signaling, and that route is speculative.
A counterintuitive detail deserves emphasis here. The herpes mechanism is often described as if lysine directly blocks the virus, but the real picture is a ratio effect: what may matter is the balance of lysine to arginine in the diet and bloodstream, not the absolute lysine dose. That is why some clinicians who use lysine for cold sores focus on reducing high-arginine foods as much as on adding lysine. In canker sores, no equivalent ratio has been defined or validated. So the popular explanation for why lysine "should" work is borrowed from a disease it does not treat.
What trials actually measured
The human evidence for lysine in canker sores is thin, old, and inconsistent. A small randomized trial published in the 1980s tested lysine against placebo in people with recurrent aphthous ulcers and reported fewer and less severe outbreaks in the lysine group. The sample was tiny, the design had limitations, and the result has not been robustly replicated in larger modern trials. Other small studies and case reports have been mixed, with some showing no clear difference from placebo. When the entire evidence base is a handful of small, decades-old trials, the honest conclusion is uncertainty, not proof.
Context helps calibrate expectations. Recurrent aphthous stomatitis affects a large share of the general population at some point, with estimates commonly ranging from roughly 5 percent to 25 percent depending on the population studied and the definition used. Most cases are mild and self-limited. That matters for interpreting any supplement trial, because a condition that often resolves on its own makes small uncontrolled studies look more impressive than they are. Without a placebo group, improvement is easy to attribute to whatever was taken.
The gold standard for a treatment claim is a large, randomized, placebo-controlled trial with clearly defined outcomes such as ulcer count, ulcer duration, and pain scores. For lysine in canker sores, that standard has not been met. This is the professional caveat that thin reviews skip: absence of evidence is not the same as evidence of absence, but it also is not a license to promise benefit. The defensible statement is that lysine has not been shown to reliably prevent or heal canker sores in well-powered studies.
Lysine versus other approaches
When people ask whether lysine helps canker sores, they are usually weighing it against other options. The table below compares common approaches on the strength of their evidence and their practical role. It is a qualitative comparison, not a ranking of effectiveness for any individual.
| Approach | Evidence for canker sores | Typical role | Practical notes |
|---|---|---|---|
| Lysine supplement | Weak and inconsistent; small old trials | Adjunct some people try | Low cost, generally low risk |
| Topical corticosteroid | Better supported for pain and duration | First-line for many clinicians | Prescription or OTC gel; follow label |
| Topical anesthetic or protective gel | Symptom relief, not healing | Comfort measure | Short-term pain control |
| Avoiding trigger foods | Anecdotal and individual | Preventive trial | Track with a diary |
| Oral vitamin B12 or iron when deficient | Helpful if a deficiency is documented | Correcting a cause | Test before supplementing |
| Chlorhexidine or antimicrobial rinse | Modest, mixed evidence | Adjunct | Can stain teeth with extended use |
The comparison makes the key point: the approaches with the best support either treat symptoms directly, such as topical steroids and anesthetics, or correct an identified deficiency. Lysine sits in a weaker tier. That does not make it worthless, but it belongs after, not instead of, better-supported measures.
Timeline of a canker sore and where lysine fits
Canker sores follow a fairly predictable course. Understanding the timeline clarifies what any treatment can realistically do, because prevention and healing are different targets.
| Stage | Typical timing | What is happening | What a treatment could target |
|---|---|---|---|
| Prodrome | Hours to 1 day before | Tingling or burning at the site | Prevention, if caught early |
| Ulcer formation | Day 1 to 2 | Round ulcer with a white or yellow center and red rim | Pain relief, limiting size |
| Peak pain | Days 2 to 4 | Maximum discomfort, often worse with eating | Symptom control |
| Healing | Days 4 to 10 | Center flattens, redness fades | Supporting repair |
| Resolution | Usually within 1 to 2 weeks | Tissue restored, often without scarring | Confirming it healed |
Most uncomplicated canker sores heal within about one to two weeks without treatment. Because the natural course is short, any intervention is hard to distinguish from spontaneous healing in a small study. This is exactly why the lysine trials are hard to interpret: if most ulcers resolve on their own within two weeks, a supplement taken for two weeks will often appear to "work."
Practical actions and thresholds
For someone considering lysine, the practical approach is to treat it as a low-stakes experiment with clear rules, not as a guaranteed remedy. The steps below are general guidance, not a personalized treatment plan; anyone with frequent, severe, or non-healing ulcers should see a clinician.
Try a short, defined trial. Use lysine for a set period, such as four to six weeks, and track ulcer count, size, duration, and pain in a simple diary. Without a before-and-after record, you cannot tell whether it helped. Do not delay better-supported care. If pain is significant, a topical corticosteroid or anesthetic gel is a more evidence-based first step than an amino acid supplement. Check for a real deficiency before supplementing blindly. Ask a clinician whether testing for vitamin B12, iron, or folate is reasonable, since correcting a documented deficiency can reduce recurrence. Watch total intake if you have kidney concerns. Lysine supplements are generally well tolerated at typical doses, but people with kidney disease should ask a clinician before adding any amino acid supplement. Set a stop rule. If there is no clear improvement after a defined trial, stop rather than continuing indefinitely.
Red-flag warnings that warrant prompt medical evaluation rather than self-treatment:
An ulcer that does not heal within about two to three weeks. Ulcers that are unusually large, deep, or rapidly multiplying. Sores accompanied by fever, weight loss, or difficulty swallowing. New ulcers in someone with a compromised immune system. Any mouth lesion that bleeds, hardens, or changes character.
Misconceptions and the limits of what can be concluded
Several misconceptions drive the popularity of lysine for canker sores. The first is conflating cold sores and canker sores. Cold sores are caused by HSV-1 and appear usually on or around the lips; canker sores are inside the mouth and are not viral. Lysine's herpes rationale simply does not map onto aphthous ulcers. The second misconception is treating a small positive trial as settled science. One small study, especially an old one, is a hypothesis, not a verdict.
The third misconception is that "natural" means "proven." Amino acids are natural and generally low-risk, but low risk is not the same as effective. A fourth is assuming that if lysine helps one person, it will help everyone; canker sores have multiple triggers, and a treatment aimed at the wrong trigger will fail even if it is biologically active. Finally, some sources imply a specific dose or schedule will prevent outbreaks. Given the weak evidence base, presenting precise dosing as established fact overstates what is known.
Reconciling the thresholds is straightforward. The healing threshold is one to two weeks for most ulcers; the evaluation threshold is about two to three weeks before a non-healing sore needs professional attention. The trial threshold for lysine is whatever period you set in advance, typically four to six weeks, so that you judge it against a defined endpoint rather than a vague impression. These three numbers answer different questions: how long a sore lasts, when to worry, and how long to test a supplement.
The bottom line on whether lysine helps with canker sores is that the evidence is weak, the mechanism is borrowed from a different disease, and better-supported options exist for both symptom relief and prevention. Lysine is inexpensive and generally low-risk, so a defined personal trial is defensible, but it should not replace proven care or delay evaluation of a sore that will not heal. Anyone making a treatment decision, especially with frequent or severe ulcers, should confirm it with a clinician who can assess their specific situation.